SCHEMBL9768598

SCHEMBL9768598

CCCCCCCCCCCCCCCCCCCCCC(=O)OC(C)(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.57
LMNA P02545 2/20 0.53
PAM P19021 2/20 0.52
CES2 O00748 3/20 0.50
CES1 P23141 3/20 0.50
MAPT P10636 2/20 0.50
MAPK1 P28482 1/20 0.50
TSHR P16473 5/20 0.48
PPARG P37231 6/20 0.48
PPARD Q03181 6/20 0.48
PPARA Q07869 6/20 0.48
HDAC11 Q96DB2 5/20 0.48
GPR84 Q9NQS5 4/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
PTPN1 P18031 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3658855 1.00 DGKA (0.57) DGKALMNAPAMCES2CES1
SCHEMBL3823631 1.00 DGKA (0.57) DGKALMNAPAMCES2CES1
SCHEMBL2918263 1.00 DGKA (0.57) DGKALMNAPAMCES2CES1
SCHEMBL3662225 1.00 DGKA (0.57) DGKALMNAPAMCES2CES1
SCHEMBL5732818 1.00 DGKA (0.57) DGKALMNAPAMCES2CES1
SCHEMBL7771101 1.00 DGKA (0.57) DGKALMNAPAMCES2CES1
SCHEMBL3121472 1.00 DGKA (0.57) DGKALMNAPAMCES2CES1
SCHEMBL9985650 1.00 DGKA (0.57) DGKALMNAPAMCES2CES1
SCHEMBL62214 1.00 DGKA (0.57) DGKALMNAPAMCES2CES1
SCHEMBL1510009 1.00 DGKA (0.57) DGKALMNAPAMCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113330024-B Method for preparing GIP/GLP1 dual agonist 伊莱利利公司 2025-06-13 CN disclosed
CN-120058563-A Preparation method of polypeptide side chain 杭州中美华东制药有限公司 2025-05-30 CN disclosed
CN-120040285-A Method for preparing long fatty chain diacid derivative and application thereof 广东东阳光药业股份有限公司 2025-05-27 CN disclosed
CN-119896736-A Pharmaceutical combination of PCSK9 inhibitor and GLP-1 receptor agonist 甘李药业股份有限公司 2025-04-29 CN disclosed
CN-119522233-A GLP-1/GIP double agonist and preparation method and application thereof 杭州中美华东制药有限公司 2025-02-25 CN disclosed
CN-119462375-A Synthesis method and application of long-chain alkane diacid mono-tert-butyl ester 四川普康药业有限公司 2025-02-18 CN disclosed
CN-119119237-A Method for preparing GIP/GLP1 dual agonist 伊莱利利公司 2024-12-13 CN disclosed
CN-119119239-A Method for preparing GIP/GLP1 dual agonist 伊莱利利公司 2024-12-13 CN disclosed
CN-119119238-A Method for preparing GIP/GLP1 dual agonist 伊莱利利公司 2024-12-13 CN disclosed
CN-119080887-A GLP-1/GIP double agonist and preparation method and application thereof 杭州中美华东制药有限公司 2024-12-06 CN disclosed
CN-117731621-A Glucagon-like peptide-1 slow release microsphere preparation and preparation method thereof 甘李药业股份有限公司 2024-03-22 CN disclosed
CN-117402219-A GLP-1/GIP double agonist and preparation method and application thereof 杭州中美华东制药有限公司 2024-01-16 CN disclosed
CN-113330024-A Method for preparing GIP/GLP1 dual agonist 伊莱利利公司 2021-08-31 CN disclosed
CN-105377884-B Derivatives of GLP-1-like peptides and uses thereof 诺和诺德股份有限公司 2021-07-20 CN disclosed
CN-110945017-A Bifunctional compounds 诺沃挪第克公司 2020-03-31 CN disclosed
CN-105377306-B GLP-1 derivatives and uses thereof 诺和诺德股份有限公司 2020-03-17 CN disclosed
EP-2584894-B1 PELARGONIC ACID FORMULATION COMPO GMBH & CO KG (DE) 2016-06-01 EP disclosed
EP-2584894-A2 PELARGONIC ACID FORMULATION COMPO GmbH & Co.KG (DE) 2013-05-01 EP disclosed
WO-2011161133-A2 PELARGONIC ACID FORMULATION COMPO GMBH& CO. KG (DE) 2011-12-29 WO disclosed
US-5030521-A Magnetic recording medium using a fatty acid ester lubricant wherein the alcohol component is branched at the number one carbon position FUJI PHOTO FILM CO., LTD. (JP) 1991-07-09 US disclosed